CSIMarket
 

Abbott Laboratories  (ABT)
Other Ticker:  
 

Abbott Laboratories's Working Capital Per Sales

ABT's Working Capital and Revenue growth



ABT Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change -27.13 % -8.67 % -12.57 % 8.05 % 25.48 %
Y / Y Revenue Change 1.49 % -2.56 % -11.36 % -18.06 % -12.01 %
Working Capital Per Revenue 0.25 0.27 0.28 0.28 0.26
Total Ranking # 941 # 1463 # 1219 # 1772 # 1044
Seq. Working Capital Change -7.03 % 1.15 % -15.2 % -8.63 % 16.53 %
Seq. Revenue Change 0.97 % 1.65 % 2.37 % -3.41 % -3.06 %





Comment on ABT's Working Capital Per Revenue in the fourth quarter 2023
Abbott Laboratories's Working Capital Per Revenue in the Q4 2023 sequentially fell to 0.25 but remained above Abbott Laboratories's average.

Within Healthcare sector 14 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Abbott Laboratories Working Capital Per Revenue overall ranking has impoved so far in the Q4 2023 to 941, from total ranking in the third quarter 2023 at 1463.
Working Capital Per Revenue Ranking
Within: No.
Industry # 5
Sector # 15
S&P 500 # 941


Working Capital Per Revenue Statistics
High Average Low
0.59
0.24
-0.01
(Sep 30 2017)  



Financial Statements
Abbott Laboratories's Working Capital $ 9,155 Millions Visit ABT's Balance sheet
Abbott Laboratories's Revenues $ 10,241 Millions Visit ABT's Income Statement
Where are ABT's Sales coming from? Visit ABT's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
Valneva Se  0.68 
Ani Pharmaceuticals Inc  0.67 
Inari Medical Inc   0.67 
Penumbra Inc   0.66 
Royalty Pharma Plc  0.64 
Koru Medical Systems Inc  0.63 
Genedx Holdings Corp   0.63 
Exelixis Inc   0.62 
Endo International Plc  0.61 
Insulet Corporation  0.60 
Sangamo Therapeutics Inc   0.60 
Artivion Inc   0.59 
Electromed Inc   0.59 
Veracyte inc   0.58 
Harmony Biosciences Holdings inc   0.57 
Qiagen N v   0.56 
Biolife Solutions Inc   0.56 
Livanova Plc  0.55 
Lantheus Holdings Inc   0.53 
Star Equity Holdings Inc   0.53 
Biogen Inc   0.53 
Zoetis Inc   0.52 
Neurocrine Biosciences Inc   0.51 
Elanco Animal Health Inc  0.50 
Nephros Inc   0.50 
Electrocore Inc   0.49 
Jazz Pharmaceuticals Plc  0.49 
Protalix Biotherapeutics inc   0.49 
Pro dex Inc   0.48 
Avanos Medical Inc   0.46 
Date modified: 2024-02-17T11:39:19+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com